For the Quarter Ending March 2026
Metronidazole Benzoate Prices in North America
- In United States, the Metronidazole Benzoate Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- A 3.3% Consumer Price Index rise in March 2026 increased logistics expenses for Metronidazole Benzoate distribution.
- The Metronidazole Benzoate Production Cost Trend increased as the Producer Price Index rose 4.0% in March 2026.
- The Manufacturing Index expanded while industrial production grew 0.7% in March 2026, constraining energy-intensive pharmaceutical synthesis output.
- Retail sales grew 4.0% and unemployment stabilized at 4.3% in March 2026, supporting steady downstream pharmaceutical consumption.
- Consumer confidence reached 91.8 in March 2026, sustaining the Metronidazole Benzoate Demand Outlook for pediatric and veterinary treatments.
- Upstream toluene feedstock costs surged in March 2026 due to intense global crude oil and energy market volatility.
- Distributors maintained comfortable inventories as Asian suppliers resumed export loadings to the US in February 2026.
- The Metronidazole Benzoate Price Forecast remained firm as pharmaceutical preparation producer prices stabilized in March 2026.
Why did the price of Metronidazole Benzoate change in March 2026 in North America?
- Upstream toluene feedstock costs surged in March 2026, significantly driving up overall pharmaceutical production expenses.
- A 4.0% Producer Price Index rise in March 2026 reflected elevated intermediate chemical manufacturing costs.
- Trans-Pacific freight upticks tightened landed costs for United States imports of materials in February 2026.
Metronidazole Benzoate Prices in APAC
- In China, the Metronidazole Benzoate Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- The Metronidazole Benzoate Production Cost Trend increased in March 2026 as producer prices grew 0.5% year-over-year.
- The Metronidazole Benzoate Demand Outlook remained steady for pediatric suspensions as consumer prices increased 1.0% in March 2026.
- Industrial production grew 5.7% in March 2026, ensuring steady availability of Metronidazole Benzoate bulk active ingredients.
- Retail sales grew 1.7% in March 2026, limiting companion animal healthcare spending for Metronidazole Benzoate treatments.
- An unemployment rate of 5.4% in March 2026 strained budgets, reducing veterinary consumption of Metronidazole Benzoate.
- Consumer confidence hit 91.6 in February 2026, dampening discretionary veterinary demand for Metronidazole Benzoate formulations.
- The Manufacturing Index expanded in March 2026, supporting an upward Metronidazole Benzoate Price Forecast trend.
- Toluene feedstock costs surged in March 2026 due to geopolitical conflicts, elevating Metronidazole Benzoate synthesis expenses.
Why did the price of Metronidazole Benzoate change in March 2026 in APAC?
- Toluene precursor costs surged in March 2026 due to severe Middle East geopolitical supply disruptions.
- Regional chemical inventories tightened in February 2026 as Chinese manufacturing plants reduced their operating rates.
- Spot market pricing surged in March 2026 following massive crude oil and energy price spikes.
Metronidazole Benzoate Prices in Europe
- In Germany, the Metronidazole Benzoate Price Index rose quarter-over-quarter in Q1 2026, driven by surging production costs.
- The Metronidazole Benzoate Production Cost Trend increased in March 2026 as inflation reached 2.7 percent.
- The Metronidazole Benzoate Price Index faced pressure as producer prices declined -0.2 percent in March 2026.
- The Manufacturing Index expanded in March 2026, supporting a stable Metronidazole Benzoate Demand Outlook for pharmaceuticals.
- Industrial production remained stagnant at 0.0 percent in February 2026, reflecting flat baseline chemical manufacturing activity.
- Retail sales grew 0.7 percent and unemployment stayed at 4.2 percent in February 2026, sustaining demand.
- Consumer confidence dropped to -24.7 in March 2026, constraining discretionary spending on veterinary antimicrobial suspensions.
- Toluene feedstock prices strengthened and energy costs spiked in March 2026, elevating upstream benzoic acid expenses.
- The Metronidazole Benzoate Price Forecast trended upward in March 2026 as the euro weakened against dollars.
Why did the price of Metronidazole Benzoate change in March 2026 in Europe?
- European chemical raw material availability tightened in March 2026 due to Middle East geopolitical conflicts.
- Energy and natural gas costs for European chemical producers spiked significantly upward during March 2026.
- Demand across the European ethylene oxide chain weakened in January 2026, impacting precursor market balances.
For the Quarter Ending December 2025
Metronidazole Benzoate Prices in North America
- In the United States, Metronidazole Benzoate Price Index rose in Q4 2025, driven by rising costs and API demand.
- Metronidazole Benzoate production costs increased; Toluene feedstock costs rose in North America in early Q4 2025.
- Producer Price Index (PPI) rose 3.0% year-over-year in November 2025, indicating higher input costs.
- Demand for active pharmaceutical ingredients surged in 2025, driven by aging population and chronic conditions.
- Retail sales increased 3.3% year-over-year in November 2025, reflecting strong consumer healthcare spending.
- Toluene inventories in North America were tighter in early Q4 2025, impacting feedstock availability.
- New U.S. tariffs on imported pharmaceutical products in October 2025 contributed to elevated API costs.
- Industrial production increased 2.0% year-over-year in December 2025, supporting the manufacturing environment.
- Consumer Price Index (CPI) increased 2.7% year-over-year in December 2025, raising operational costs.
- A 4.4% unemployment rate and 89.1 consumer confidence in December 2025 supported healthcare product demand.
Why did the price of Metronidazole Benzoate change in December 2025 in North America?
- Rising Toluene feedstock costs in North America in early Q4 2025 elevated production expenses.
- Increased U.S. tariffs on imported pharmaceutical products in October 2025 raised API costs.
- Robust demand for active pharmaceutical ingredients throughout 2025 supported price trends.
Metronidazole Benzoate Prices in APAC
- In China, the Metronidazole Benzoate Price Index fell quarter-over-quarter in Q4 2025, influenced by producer price deflation.
- Metronidazole Benzoate production costs declined in Q4 2025, as carbon prices plummeted in October 2025.
- Demand for Metronidazole Benzoate remained robust in Q4 2025, driven by China's expanding pharmaceutical market.
- Industrial production grew by 5.2% in December 2025, supporting Metronidazole Benzoate demand for pharmaceutical end-use.
- The Manufacturing Index expanded in December 2025, indicating growth across the broader manufacturing sector.
- China's CPI was 0.8% in December 2025, reflecting weak general inflation, impacting API pricing.
- Chemical exports from China experienced robust growth in Q4 2025, diversifying towards emerging economies.
- Metronidazole Benzoate price forecast suggests continued pressure from chemical overcapacity throughout 2025.
- Weak consumer spending, with retail sales up only 0.9% in December 2025, indirectly affected market sentiment.
Why did the price of Metronidazole Benzoate change in December 2025 in APAC?
- Producer Price Index declined by 1.9% in December 2025, lowering manufacturing costs.
- China's chemical sector faced significant overcapacity throughout 2025, intensifying competition.
- Carbon prices plummeted in October 2025, easing operational expenses for manufacturers.
Metronidazole Benzoate Prices in Europe
- In Germany, the Metronidazole Benzoate Price Index rose quarter-over-quarter in Q4 2025, driven by climbing feedstock valuations.
- Metronidazole Benzoate Price Forecast trends reflected support from Benzoic Acid prices, which climbed in December 2025.
- Metronidazole Benzoate Production Cost Trend increased as Ethylene prices heated up in Europe during Q4 2025.
- Metronidazole Benzoate Demand Outlook strengthened when antibiotic consumption rates spiked seasonally in Q4 2025 due to illness.
- While the broader PPI fell 2.5% in December 2025, specific pharmaceutical feedstock markets resisted this downward trend.
- Industrial production rose 1.3% in November 2025, supporting consistent Metronidazole Benzoate output despite logistical congestion.
- Retail sales grew 1.1% in November 2025, confirming steady downstream pharmacy offtake for antimicrobial formulations.
- The Manufacturing Index sentiment contracted in December 2025, though pharmaceutical production expanded earlier in October 2025.
- With CPI stabilizing at 1.8% in December 2025, operational overheads for manufacturers remained predictable during the quarter.
Why did the price of Metronidazole Benzoate change in December 2025 in Europe?
- Benzoic Acid feedstock prices in Europe climbed in December 2025, directly raising manufacturing expenses.
- Antibiotic consumption rates spiked in Q4 2025, tightening market availability for essential pharmaceutical ingredients.
- Supply chains faced renewed strain and congestion in late 2025, adding logistical premiums to prices.
